PATENT CLAIM ANALYSIS

Application Number: 15917478
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "443000"]

Abstract:
Rivastigmine transdermal compositions are provided. Aspects of the transdermal compositions include an active agent layer which includes rivastigmine and a solubility modulator, e.g., crosslinked acrylic acid polymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.

Claim (Index 63):
The composition according to  claim 57 , wherein the coat weight of the active agent layer ranges from 10 mg/cm 2  to 90 mg/cm 2 .

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.46875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14666117', '13427602', '14893020', '13994242', '14064006']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7256005221762726
- 35 USC 102 Novelty (BERT): 0.5536731536017485
- Combined Prediction Score: 0.7084077853188201
- Mean Citation Score: 221.093342
- Max Citation Score: 441.9359
- Similarity Product: 289.52442520416975

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test